Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.160
-0.030 (-2.52%)
Jan 9, 2026, 4:00 PM EST - Market closed
Phio Pharmaceuticals Market Cap
Phio Pharmaceuticals has a market cap or net worth of $12.49 million as of January 9, 2026. Its market cap has increased by 223.22% in one year.
Market Cap
12.49M
Enterprise Value
1.78M
1-Year Change
223.22%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since May 10, 2012, Phio Pharmaceuticals's market cap has decreased from $42.54T to $12.49M, a decrease of -100.00%. That is a compound annual growth rate of -66.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 12.49M | 10.48% |
| Dec 31, 2025 | 11.30M | 262.46% |
| Dec 31, 2024 | 3.12M | 67.92% |
| Dec 29, 2023 | 1.86M | -63.48% |
| Dec 30, 2022 | 5.08M | -62.43% |
| Dec 31, 2021 | 13.53M | -12.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 979.55B |
| Johnson & Johnson | 495.52B |
| AbbVie | 395.03B |
| UnitedHealth Group | 312.32B |
| AstraZeneca | 295.31B |
| Merck & Co. | 277.56B |
| Novartis AG | 273.11B |
| Novo Nordisk | 256.73B |